For his top conservative stock pick for the coming year, J. Royden Ward, Chief Analyst of Cabot Benjamin Graham Value Investor, looks to a leading offshore oil and natural gas drilling company.
Ensco PLC (ESV) owns and operates shallow water and ultra-deepwater rigs, located in many parts of the world.
Two new drilling rigs are ready to begin multi-year contracts with major international oil companies. Six more rigs are under construction.
In addition, Ensco is spending heavily on standardizing and modernizing its drilling fleet, which will help the company maintain its advantage over competitors.
Demand for Ensco's drilling rigs is solid, and will likely strengthen further during the next several years. Sales will rise 15% in 2014, and EPS will climb 17% to 7.20.
Ensco has been named Number One in total customer satisfaction for the third consecutive year. The low current P/E (price to 2013 earnings) ratio of 8.9 and the high dividend yield of 5.5% are very attractive.
Hot Performing Companies To Own For 2015: The Babcock & Wilcox Co (BWC)
The Babcock & Wilcox Company (B&W), incorporated on March 8, 2010, is a technology innovator in power generation systems, a specialty constructor of nuclear components and a service provider in its segments. The Company provides a variety of products and services to customers in the power and other steam-using industries, including electric utilities and other power generators, industrial customers in various other industries, and the United States Government. The Company operates in four business segments: Power Generation, Nuclear Operations, Technical Services and Nuclear Energy.
Power Generation
Through Power Generation segment, the Company supplies boilers fired with fossil fuels, such as coal, oil and natural gas, or renewable fuels, such as biomass, municipal solid waste and concentrated solar energy. In addition, the Company supplies environmental equipment and components and related services to customers in different regions around the world. The Company designs , engineers, manufactures, supplys, constructs and services utility and industrial power generation systems, including boilers used to generates steam in electric power plants, pulp and paper making, chemical and process applications and other industrial uses.
Power Generation segment specializes in engineering, manufacturing, procurement and erection of equipment used in the power generation industry and various other industries, and the provision of related services, including engineered-to-order services, products and systems for energy conversion worldwide and related auxiliary equipment, such as burners, pulverizers, soot blowers and ash handling systems; heavy-pressure equipment for energy conversion, such as boilers fueled by coal, oil, bitumen, natural gas, municipal solid waste, biomass and other fuels; environmental control systems, including both wet and dry scrubbers for flue gas desulfurization, modules for selective catalytic reduction of the oxides of nitrogen, equipment to capture! particulate matter, such as fabric filter baghouses and wet and dry electrostatic precipitators, and similar devices, and power plant equipment and related heavy mechanical erection services.
The Company supports primarily fossil operating plants with a variety of additional services, including the installation of new systems and replacement parts, engineering services, construction, inspection, maintenance and field technical services, such as condition assessments and inventory services. The Company offers a range of construction services through a wholly owned subsidiary including erection of utility and industrial boiler plants and installations of cogeneration facilities and pollution control equipment, such as selective catalytic reduction systems and flue gas desulfurization scrubbers.
The Company also provides power through cogeneration, refuse-fueled power plants and other independent power-producing facilities. In this market, the Company owns and operates facilities, supply equipment and serve as contractors for engineer-procure-construct services and operations and maintenance.
Nuclear Operations
Through Nuclear Operations segment, the Company engineers , design and manufactures precision naval nuclear components and reactors for the United States Department of Energy (DOE)/National Nuclear Security Administration's (NNSA) Naval Nuclear Propulsion Program.The Company's Nuclear Operations segment specializes in the design and manufacture of close-tolerance and equipment for nuclear applications. In addition, the Company is a manufacturer of critical nuclear components, fuels and assemblies for government and limited commercial uses. The Company also converts or downblend high-enriched uranium into low-enriched fuel for uses in commercial reactors to generate electricity. The Company has also been a provider in the receipt, storage, characterization, dissolution, recovery and purification of a variety of uranium-bearing materials. All phases! of urani! um downblending and uranium recovery are provided at the Company's Lynchburg, Virginia and Erwin, Tennessee sites.
The Company works closely with the DOE-supported nuclear non-proliferation program. This program is assisting in the development of a high-density, low-enriched uranium fuel required for high-enriched uranium test reactor conversions.
Technical Services
Through Technical Services segment, the Company provides various services to the United States Government, including uranium processing, environmental site restoration services and management and operating services for various United States Government-owned facilities. These services are provided to the DOE, including the NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
The Company�� principal operations include managing and operating nuclear production facilities; managing and operating environmental management sites; managing spent nuclear fuel and transuranic waste for the DOE, and providing critical skills and resources for DOE sites.The Company manages and operates complex, high-consequence nuclear and national security operations for the DOE and the NNSA, primarily through its joint ventures. The Company's Technical Services segment's overall activity primarily depends on authorized spending levels of the DOE, NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
Nuclear Energy
Through Nuclear Energy segment, the Company supplies commercial nuclear steam generators and components to nuclear utility customers. In addition, this segment offers a full spectrum of services for steam generators and balance of plant equipment, as well as nondestructive examination and tooling/repair solutions for other plant systems and components. The Company's Nuclear Energy segment fabricates pressure vessels, reactors, stea! m generat! ors, heat exchangers and other auxiliary equipment. This segment also provides specialized engineering and maintenance services and power plant construction. This segment specializes in performing full scope, prototype design work coupled with manufacturing integration. The Company is developing the B&W mPower reactor, a small modular reactor design with the flexibility to provide between 180 megawatts to greater than 1,000 megawatts of electrical power generation (in increments of 180 megawatts) and the capacity to operate for a four year operating cycle without refueling.
The Company competes with Alstom S.A., Doosan Babcock, Babcock Power, Inc., Foster Wheeler AG., Hitachi, Ltd., Bechtel National, Inc., URS Corporation, CH2M Hill, Inc., Fluor Corporation, Lockheed Martin Corporation, Jacobs Engineering Group, Inc., AREVA Inc., EnergySolutions, Inc. and Northrop Grumman Corporation.
Advisors' Opinion:- [By The Energy Report]
JH: One of the areas where the U.S. for decades has been the leading technological power is in small nuclear reactors. We've used them on our aircraft carriers and on our nuclear submarines safely and efficiently. The U.S. has an advantage in understanding small modular nuclear reactors. One of the companies that we have followed for a long time that's working on that is Babcock & Wilcox Co. (BWC). There's also Fluor Corp. (FLR), which is working on small modular nuclear reactors. President Obama and the Department of Energy are funding research on the implementation of small modular nuclear reactors.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Babcock & Wilcox (NYSE: BWC ) , whose recent revenue and earnings are plotted below. - [By Michael J. Carr]
The Babcock & Wilcox Co. (NYSE: BWC) is a leader in the nuclear power industry. The company makes nuclear reactors for submarines and aircraft carriers, and even with cutbacks in defense spending, it reported a $2.8 billion backlog in that sector. The company also has a backlog of $2.3 billion in its power generation business segment.
Top 5 High Dividend Companies To Watch For 2014: Syngenta AG(SYT)
Syngenta AG, an agribusiness company, engages in the discovery, development, manufacture, and marketing of a range of products designed to enhance crop yields and food quality worldwide. The company operates in three segments: Crop Protection, Seeds, and Business Development. The Crop Protection segment offers herbicides for corn, cereals, soybean, and rice; fungicides for corn, cereals, fruits, grapes, rice, soybean, and vegetables; insecticides for fruits, vegetables, and field crops; seed care for corn, soybean, cereals, and cotton; and professional products, such as products for public health, and turf and ornamentals. This segment markets its products through independent distributors and dealers, agricultural consultants, and growers. The Seeds segment develops, produces, and markets seeds and plants based on advanced genetics and related technologies. This segment provides approximately 200 product lines and approximately 6,800 varieties of proprietary genetics, incl uding vegetables, flowers, corn, soybean, sugar beet, and sunflower primarily under the NK, Golden Harvest, Garst, HILLESH�, S&G, Rogers, Zeraim Gedera, and Fischer brand names. The Business Development segment engages in the development of enzymes and traits to enhance agronomic, nutritional, and biofuel properties of plants. The company was founded in 1999 and is headquartered in Basel, Switzerland.
Advisors' Opinion:- [By Rich Duprey]
Just as Monsanto is enjoying a surge in sales of Roundup, pesticide makers are witnessing greater sales of pesticides to combat these superbugs. Revenues at Sygenta (NYSE: SYT ) rose 1.5% to $4.2 billion, FMC's (NYSE: FMC ) sales were 5% higher, and American Vanguard's (NYSE: AVD ) surged 39% last quarter. The three companies account for three-quarters of all ground pesticides sold in the United States.
- [By Rich Duprey]
The invincibility of genetically modified crops may be starting to crumble under its own weight, with�Syngenta� (NYSE: SYT ) being the latest biotech to stress-test their resilience.
- [By Vanina Egea]
The battle on the field continues. Monsanto (MON) and Syngenta (SYT) are expected to enter the seed business with a strong bid. Both companies stand at the top of the agricultural inputs industry, and continue to look for ways to improve performance. Let us see what some gurus think about their future prospects, and if they see them fit for a long term investment.
- [By Rich Duprey]
Not every crop is so protected. Between�Monsanto,�DuPont� (NYSE: DD ) , and�Syngenta� (NYSE: SYT ) -- the "three sisters" of GMO seeds -- they�control 53% of the world's seed production, yet their control of our food supply is almost universal because of their cross-licensing�agreements among themselves and with others, like Dow Chemical (NYSE: DOW ) .
Top 5 High Dividend Companies To Watch For 2014: Allergan Inc. (AGN)
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the La p-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Ben Levisohn]
UBS analyst Marc Goodman explains why he raised Allergan (AGN) to Buy from Neutral following yesterday’s financial results and cost-cutting moves:
Reuters Allergan Chief Executive David PyottInvestors have been waiting for 2 Allergan events: a restructuring and an accretive deal. Given the Friday PR for the conf call [yesterday], many investors were expecting a deal to be announced today and thus were disappointed from that perspective. But the cost cutting was solid and viewed positively (on top of the very strong qtr), and mgt couldn’t have been more confident that it can get a deal done in time. Now we wait for this deal. Can Allergan create close to as much ST value as Valeant (VRX) can with its cost cuts?
Before�[yesterday] Valeant’s cost synergy targets (R&D) were already suspect because Valeant mgt indicated that it would cut $900M of a $1.1B budget and yet still pursue attractive late-stage pipeline projects. Allergan pointed to >$200M of post-approval commitments and >$300M of spend to accomplish those projects. Hence, we had already assumed that Valeant would need to change either its synergies or sacrifice projects (we assume cut projects). This is not only what it did with both Medicis and B&L but eliminating R&D is part of the b-model. With [yesterday's] cuts Allergan�� cost base is ~$3.5B and Valeant�� planned $2.7B of synergies would account for >75% of costs. Cost synergies are critical to determine deal accretion for Valeant, and so it will be interesting to see what Valeant will do with its aggressive targets.
Shares of Allergan are little changed at $171.22 at 2:10 p.m. today, while Valeant has dropped 1.3% to $123.97.
- [By Jayson Derrick]
A U.S. District Court ruled that Valeant Pharmaceuticals (NYSE: VRX) and Bill Ackman's Pershing Square could vote at Allergan's (NYSE: AGN) special shareholder meeting on December 18. Shares of Valeant gained 0.57 percent, closing at $133.61 while shares of Allergan hit new 52-week highs of $196.54 before closing the day at $195.12, up 1.03 percent.
Top 5 High Dividend Companies To Watch For 2014: Computer Task Group Inc (CTG)
Computer Task Group, Incorporated (CTG), incorporated on March 11, 1966, is an information technology (IT) solutions and staffing company with operations in North America and Europe. CTG provides IT services to its clients, which includes IT Solutions and IT Staffing. During the year ended December 31, 2011, the Company had six operating subsidiaries: Computer Task Group of Canada, Inc., providing services in Canada; and Computer Task Group Belgium N.V., CTG ITS S.A., Computer Task Group IT Solutions, S.A., Computer Task Group Luxembourg PSF, and Computer Task Group (U.K.) Ltd., each were providing services in Europe. Services provided in North America are performed by CTG. It provides services to all of the markets, which it serves. The services provided encompass the IT business solution life cycle, including phases for planning, developing, implementing, managing, and maintaining the IT solution. In February 2013, it acquired etrinity from i-Cros Nv of Antwerp, Belgium.
The Company promotes its services through four vertical market focus areas: technology service providers; healthcare, which includes services provided to healthcare providers, health insurers (payers), and life sciences companies; energy, and financial services. At December 31, 2011, CTG provided IT services to approximately 300 clients in North America and Europe. In North America, the Company operates in the United States and Canada. In Europe, the Company operates in Belgium, Luxembourg, and the United Kingdom.
IT Solutions
CTG�� services in IT solution area include helping clients assess their business needs and identifying the IT solutions. The services delivered by the Company include the selection and implementation of packaged software and the design, development, testing, and integration of new systems, and the development and implementation of customized software and solutions designed to fit the needs of a specific client or vertical market. Also included in IT Solutions is Trans! itional Application Management (TAM).
In 2011, the healthcare market accounted for most of CTG�� TAM business. In 2011, CTG continued to invest in new IT solutions development, primarily targeted to the healthcare market, which support cost reductions and productivity improvements. In 2011, several healthcare solutions under development moved from the pilot stage of testing using live data into the sales process as completed tools. These solutions include medical fraud, waste, and abuse detection and reduction, medical care and disease management, and group insurance underwriting risk assessment. The Company has developed software to support these offerings. These solutions support both the healthcare provider and payer markets.
IT Staffing
The Company recruits, retains, and manages IT talent for its clients, which are technology service providers and companies with multiple locations and need for external IT resources. The Company also supports companies and organizations that need to augment their own IT staff on a flexible basis. It provides IT talent services on a temporary or long-term basis. CTG�� recruiting organization works with customers to define their staffing requirements. The primary focus of the Company�� staffing business is a managed services model that provides clients with support through supply models customized to client needs, resource management support, vendor management programs, and a automated recruiting process and system. During 2011, its IT staffing service generated 63% of its total revenue.
Advisors' Opinion:- [By Seth Jayson]
Computer Task Group (Nasdaq: CTG ) reported earnings on July 22. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 28 (Q2), Computer Task Group missed estimates on revenues and met expectations on earnings per share. - [By Anna Prior]
Information technology staffing and solutions company Computer Task Group Inc.(CTG) cut its outlook for its second-quarter and full-year results, primarily due to higher medical costs.
No comments:
Post a Comment